🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Healthy Subjects or Volunteers

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants NCT07766369Phase 11 site📍 Austin Eisai Inc. · Tests: E2086 Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis NCT04755699EARLY Phase 11 site📍 Manhasset Northwell Health · Tests: Transcutaneous Electrical Stimulation Safety and Normative Data With Neos™ NCT07258212n/a3 sites📍 Bern📍 Bern📍 Bern machineMD AG A Study Testing the Safety and Effects of FB102 in Healthy Volunteers NCT07623057Phase 12 sites📍 Eastwood📍 Maroochydore Forte Biosciences, Inc. · Tests: FB102 Single dose - Part A, FB102 Multiple doses - Part B, FB102 Placebo, FB102 Multiple doses - Part C Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers NCT03207854n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Laboratory Biomarker Analysis, Questionnaire Administration Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies NCT00114647n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults NCT07526116Phase 11 site📍 Ghent Regeneron Pharmaceuticals · Tests: REGN22044, Placebo Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe NCT07282795n/a15 sites📍 Goyang-si📍 Gunpo📍 Busan Sanofi · Tests: Efluelda® Pre-filled syringe Training and Testing Database for IMU Based Gait Analysis Methods NCT07236008n/a1 site📍 Brussels Vrije Universiteit Brussel A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma NCT07660731Phase 11 site📍 New Haven Pfizer · Tests: PF-08103402, Placebo, Midazolam Deep Phenotyping of CIndU NCT07359430n/a3 sites📍 Leiden📍 Rotterdam📍 Utrecht Centre for Human Drug Research, Netherlands Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers NCT07184502Phase 12 sites📍 Brisbane📍 Melbourne Beijing QL Biopharmaceutical Co.,Ltd · Tests: ZT003 - Part1 (Single ascending dose ), ZT003 - Part 2(Multiple ascending dose ) A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma NCT07436949Phase 1, Phase 212 sites📍 Beijing📍 Guangzhou📍 Changsha Bambusa Therapeutics · Tests: BBT002, Placebo GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE NCT06620185NA1 site📍 London Imperial College London · Tests: FLUENZ, Influenza challenge virus A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers. NCT07426718n/a1 site📍 Portsmouth Portsmouth Hospitals NHS Trust · Tests: No intervention A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis NCT05951816Phase 11 site📍 Knoxville University of Tennessee Graduate School of Medicine · Tests: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) NCT06917742Phase 13 sites📍 Herston📍 Bayswater📍 Nedlands Capstan Therapeutics · Tests: CPTX2309, CPTX2309 Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations NCT07786467NA1 site📍 Erie Lake Erie College of Osteopathic Medicine · Tests: Osteopathic Manipulation, Osteopathic manipulation, Sham A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity NCT07578584Phase 11 site📍 Neuss Novo Nordisk A/S · Tests: NNC0497-0040, Placebo A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH NCT05945537Phase 111 sites📍 Camperdown📍 Campbelltown📍 Newcastle Inipharm Australia Pty Ltd · Tests: INI-822 (A), Placebo (B) A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) NCT06944925Phase 114 sites📍 Bowling Green📍 Owensboro📍 New York Bambusa Therapeutics · Tests: BBT002, Placebo Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation NCT07073989NA1 site📍 Móstoles Julio S. Lora Millán · Tests: Afferent stimulation Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia NCT06584357n/a26 sites📍 Atlantis📍 Aventura📍 Clermont GAP Innovations, PBC · Tests: Biomarker Data Collection, MK6240 A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants NCT07673120Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-313, Placebo, ABBV-313, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy